Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

First CRISPR test for the coronavirus approved in the United States

The kit has been granted approval under ‘emergency use’ provisions, and should help to ease testing backlogs in the country.
  1. Giorgia Guglielmi
    View author publications

    You can also search for this author in PubMed  Google Scholar

The US drug regulator has granted its first emergency-use approval for a new coronavirus test that takes advantage of the gene-editing technology CRISPR.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-020-01402-9

Updates & Corrections

  • Clarification 11 May 2020: The story has been updated to include James Collins’s contribution.

References

  1. Gootenberg, J. S. et al. Science 356, 438–442 (2017).

    Article  PubMed  Google Scholar 

  2. Myhrvold, C. et al. Science 360, 444–448 (2018).

    Article  PubMed  Google Scholar 

  3. Broughton, J. P. et al. Nature Biotechnol. https://doi.org/10.1038/s41587-020-0513-4 (2020).

    Article  PubMed  Google Scholar 

  4. Curti, L. et al. Preprint at bioRxiv https://doi.org/10.1101/2020.02.29.971127 (2020).

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links